New Market Research Report: Fina Biotech - Product Pipeline Analysis, 2013 Update
Fina Biotech (Fina) is a biotechnology company. The company selects, finances, develops and sells biotechnology projects. Its in vitro diagnostic products include Halosperm and F-12. Fina's investment areas include cell therapy with autologous adult stem cellsglioblastoma tumor therapy, diagnosis or prognosis of cancer, Alzheimer's disease, cardiovascular disease, restenosis risk markers, fertility halosperm and markers of liver damage. The company works in the field of cell therapy with autologous adult stem cells such as proteomics, genomics, genomics and proteomics, cell therapy,...
View full press release